THE ASSOCIATION BETWEEN EXPRESSION OF UCP2 AND SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY FOR OVARIAN SEROUS CARCINOMA

被引：0
|
作者：
Kawanishi, M. [1 ]
Fukuda, T. [1 ]
Inoue, Y. [1 ]
Shimomura, M. [1 ]
Matsubara, H. [1 ]
Wada, T. [1 ]
Tasaka, R. [1 ]
Yasui, T. [1 ]
Sumi, T. [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Obstet & Gynecol, Osaka, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0211
引用
收藏
页码：1495 / 1495
页数：1
相关论文
共 50 条
  • [41] Paclitaxel (Taxol) monotherapy in the treatment of progressive and recurrent ovarian carcinoma after platinum-based chemotherapy
    Blom, R
    Palm, N
    Simonsen, E
    ACTA ONCOLOGICA, 1996, 35 (06) : 733 - 736
  • [42] Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
    Yang, Ling
    Xie, Hong-Jian
    Li, Ying-Ying
    Wang, Xia
    Liu, Xing-Xin
    Mai, Jia
    ONCOLOGY REPORTS, 2022, 47 (04)
  • [43] Risk of leukemia after platinum-based chemotherapy for ovarian cancer
    Travis, LB
    Holowaty, EJ
    Bergfeldt, K
    Lynch, CF
    Kohler, BA
    Wiklund, T
    Curtis, RE
    Hall, P
    Andersson, M
    Pukkala, E
    Sturgeon, J
    Stovall, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (05): : 351 - 357
  • [44] BEVACIZUMAB AND PLATINUM-BASED CHEMOTHERAPY IN RELAPSED OVARIAN CANCER TREATMENT
    Davidenko, I.
    Kazantseva, M.
    Porhanova, N.
    Potemin, S.
    Oganyan, M.
    Syrota, L.
    Shmatkova, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [45] Association between expression of glutathione-associated enzymes and response to platinum-based chemotherapy in head and neck cancer
    Nishimura, T
    Newkirk, K
    Sessions, RB
    Andrews, PA
    Trock, BJ
    Rasmussen, AA
    Montgomery, EA
    Bischoff, EK
    Hanigan, MH
    Cullen, KJ
    CHEMICO-BIOLOGICAL INTERACTIONS, 1998, 112 : 187 - 198
  • [46] Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy
    Tortorella, Lucia
    Langstraat, Carrie L.
    Weaver, Amy L.
    McGree, Michaela E.
    Bakkum-Gamez, Jamie N.
    Dowdy, Sean C.
    Cliby, William A.
    Keeney, Gary L.
    Sherman, Mark E.
    Weroha, Saravut J.
    Mariani, Andrea
    Podratz, Karl C.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (02) : 291 - 296
  • [47] Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?
    Ayhan, A
    Taskiran, C
    Yigit-Celik, N
    Bozdag, G
    Gultekin, M
    Usubutun, A
    Guler, N
    Yuce, K
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (02) : 484 - 489
  • [48] Association of UBE2L6 and ABCB6 Expression With Platinum Resistance in Serous Ovarian Carcinoma
    Shibahara, Mami
    Kurita, Tomoko
    Murakami, Midori
    Harada, Hiroshi
    Koi, Chiho
    Izumi, Hiroto
    Yoshino, Kiyoshi
    ANTICANCER RESEARCH, 2023, 43 (08) : 3787 - 3792
  • [49] Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer
    Mise, Branka Petric
    Telesmanic, Vesna Dobric
    Tomic, Snjezana
    Sundov, Dinka
    Capkun, Vesna
    Vrdoljak, Eduard
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (02) : 347 - 356
  • [50] Primary serous adenocarcinoma of the retroperitoneum with a response to platinum-based chemotherapy: a case report
    Fujiwara, K
    Oda, T
    Suzuki, S
    Kohno, I
    Hirokawa, M
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (02) : 170 - 172
12345